News Digest on Biotech & Pharma Industry #11 | Cromos Pharma
Clinical Research Focus. 11th Edition Serbia – The Land of Opportunity in Clinical Research Over the years, Serbia has become a highly reputable location to conduct clinical research. The country has actively strived towards developing a robust healthcare system and adopted full GCP compliance. There are 322 clinical trials currently occurring inside Serbia’s borders. Increasing number of biotechnology and pharmaceutical Read more
clinical trials in Serbia, clinical research in Serbia, CRO in serbia, clinical trials in Serbia statistics, data on clinical trials in Serbia
Serbia – a land of opportunity for clinical research The past, the present, and the future When someone mentions Serbia in a scientific context, the name of Nicola Tesla inevitably comes to mind. But very few people know that Serbia has produced some of the truly great minds in medicine. One such scientist is Miodrag Radulovacki, who is considered to be the father of Read more
News Digest on Biotech & Pharma Industry #10 | Cromos Pharma, clinical trials news, recent clinical trials
Clinical Research Focus. 10th Edition Türkiye – a Hidden Gem in Clinical Research Turkey, or Türkiye as it has been officially decreed by the UN, is the perfect location for conducting clinical research. Situated between Europe and Asia, Türkiye boasts a broad and diverse population of over 85 million. With a well-developed healthcare system, a relatively low per capita number Read more
rare diseases cro, clinical research of rare diseases, challenges in clinical research of rare diseases, future of rare diseases clinical trials
The Not so Rare “Rare” Diseases Current and future challenges in clinical research of rare diseases What are rare diseases? As implied in its name, rare diseases affect small percentages of patients. However, when factoring in the multitude of rare diseases, the overall number of people affected by them is a staggering 475 million worldwide. According to the National Institutes of Read more

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM